SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-324510
Filing Date
2021-11-09
Accepted
2021-11-09 16:23:57
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d241052d8k.htm   iXBRL 8-K 26168
2 EX-99.1 d241052dex991.htm EX-99.1 62886
6 GRAPHIC g241052g1109083521365.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-324510.txt   229116

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20211109.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20211109_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20211109_pre.xml EX-101.PRE 11416
7 EXTRACTED XBRL INSTANCE DOCUMENT d241052d8k_htm.xml XML 3355
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 211392569
SIC: 2834 Pharmaceutical Preparations